| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.088 | 0.06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.079 | 0.07 |